# Global biotechnology market growth projections

> Live situation record from CLSTR: https://clstr.news/situations/global-biotechnology-market-growth-projections
> Updated: 2026-08-31T07:56:20.000Z. Sources: 8. Developments: 3.

The biotechnology market is experiencing projected growth across several specialized sectors, driven by advancements in pharmaceutical research and therapeutic manufacturing.

In the fields of bioconjugation and biosimulation, growth is fueled by demand for targeted therapeutics like antibody–drug conjugates and the adoption of computational methods, including artificial intelligence, to optimize clinical trials. The bioconjugation market is expected to grow at a compound annual growth rate (CAGR) of 13% over the next five years, though high manufacturing costs and regulatory complexities remain challenges. The biosimulation market is forecasted to expand from approximately USD 4.27 billion in 2026 to USD 9.24 billion by 2031, representing a CAGR of 16.7%.

Parallel growth is anticipated in the bioprocess analyzers and biobanking sectors. The bioprocess analyzers market, valued at USD 2.42 billion in 2025, is expected to reach USD 7.71 billion by 2035 due to increased production of biologics and the use of real-time monitoring. The biobanking market is forecasted to grow from USD 8.09 billion in 2026 to USD 12.38 billion by 2031, supported by the expansion of cell and gene therapy pipelines and the integration of automation and digital technologies.

Furthermore, the biopharmaceutical manufacturing sector is seeing significant growth in specialized production technologies. The continuous bioprocessing market is projected to reach USD 2.33 billion by 2035, driven by the need for efficient, scalable production. Simultaneously, the single-use bioreactors market is expected to grow from an estimated USD 5.43 billion in 2026 to USD 9.58 billion by 2031 as manufacturers adopt flexible, disposable systems to reduce contamination risks.

## Timeline

### 2026-08-31: Biopharmaceutical manufacturing markets for bioprocessing and bioreactors projected to grow

The biopharmaceutical manufacturing markets for continuous bioprocessing and single-use bioreactors are projected to see significant growth through 2035, driven by demand for biologics and advanced therapies.

4 sources. https://clstr.news/cluster/biopharmaceutical-manufacturing-markets-for-bioprocessing-and-bioreactors-projected-to-grow

### 2026-08-20: Biotechnology markets for bioprocess analyzers and biobanking projected to grow

The bioprocess analyzer and biobanking markets are set for significant growth through 2035, driven by rising demand for biologics, cell and gene therapies, and advanced automation technologies.

2 sources. https://clstr.news/cluster/biotechnology-markets-for-bioprocess-analyzers-and-biobanking-projected-to-grow

### 2026-08-14: Biotechnology markets for bioconjugation and biosimulation projected to grow

Global bioconjugation and biosimulation markets are set for high growth, driven by demand for targeted therapeutics and computational drug development through 2031.

2 sources. https://clstr.news/cluster/biotechnology-markets-for-bioconjugation-and-biosimulation-projected-to-grow

---
Cite as: Global biotechnology market growth projections. CLSTR, https://clstr.news/situations/global-biotechnology-market-growth-projections